Nirvana Life Sciences Inc.
Nirvana Life Sciences Inc.
CSE Index:
Currency:
Nirvana Life Sciences Inc. is focused on developing medical products and regimens that address addiction. Nirvana is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency and other health problems.
Nirvana Life Sciences Inc. (NIRV)
SEDAR Information
Company Info
Address
Suite 2110, 650 West Georgia Street
Vancouver, BC V6B 4N8
CanadaPhone
(604) 401-8100Email
Info@nirvanalifescience.comWebsite
https://nirvanalifescience.comListing date
Thursday, March 17, 2022Transfer Agent
Computershare Investor Services Inc.Capitalization
Issued & Outstanding:
33020139Reserved for Issuance:
300000News Releases
10/10/2023
MCTO Update
Bulletins
16/03/2022
2022-0319 - New Listing - Nirvana Life Sciences Inc. (NIRV)
le 16 mars/March 2022
The common shares of Nirvana Life Sciences Inc., have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.